Somewhere between the prescription pad and the unplanned pregnancy, a common antibiotic has drawn a quiet shadow. Researchers at the University of Florida, reading through years of insurance records, found that women who took doxycycline in the first trimester lost pregnancies more often than women given other antibiotics. The finding is a link, not a verdict: the records show a pattern, but not yet why it appears. It arrives in a long human story in which people must treat illness while still learning whether they are carrying a child, and it asks doctors to weigh that uncertainty with care.
Common Antibiotic Doxycycline Linked to Higher Miscarriage Risk in Early Pregnancy, Study Finds
Women exposed to doxycycline in early pregnancy showed higher rates of pregnancy loss in the study, though causation is not established.
A link, not a cause: doxycycline and early pregnancy loss
Mark
What is the headline finding here?
Mimi
Women who filled a doxycycline prescription in the first trimester had a significantly higher miscarriage risk than women given other antibiotics, such as amoxicillin, macrolides or topical clindamycin.
Mark
How big was the dataset?
Mimi
Over 218,000 claims were for respiratory infections and 6,636 were for acne, drawn from commercial and Medicaid databases.
Luke
Does it show the drug causes miscarriage?
Mimi
No. Dr Gallo said it shows a link, not a cause.
Luke
And the acne result?
Mimi
Weaker. The risk appeared only in the commercial claims data, not Medicaid, so I'd hold that one loosely.
Mark
Why would anyone take it while pregnant?
Mimi
Often the pregnancy is unplanned, so exposure happens before the woman knows.
Luke
What is still unknown?
Mimi
What happens to babies carried to term. The study looked only at pregnancy loss, and the DNA-damage evidence so far comes from animals.
Mark
What should doctors do?
Mimi
Prof Tremellen says to consider alternatives for women not on reliable contraception, where suitable ones exist.
El Pulso
- A widely prescribed antibiotic is showing a troubling association with miscarriage when taken in early pregnancy.
- Many pregnancies are unplanned, so women often take the drug before they know they are expecting.
- The signal is strongest in respiratory infection treatment and weaker in acne patients, appearing only in commercial claims data.
- Experts are urging doctors to weigh alternatives for women not using reliable contraception, while researchers push for answers on babies carried to term.
Somewhere between the prescription pad and the unplanned pregnancy, a common antibiotic has drawn a quiet shadow. Researchers at the University of Florida, reading through years of insurance records, found that women who took doxycycline in the first trimester lost pregnancies more often than women given other antibiotics. The finding is a link, not a verdict: the records show a pattern, but not yet why it appears. It arrives in a long human story in which people must treat illness while still learning whether they are carrying a child, and it asks doctors to weigh that uncertainty with care.
Researchers at the University of Florida have found a connection between doxycycline, a common antibiotic used for urinary infections, acne and respiratory illness, and a higher chance of miscarriage when it is taken in the first trimester. The drug is not recommended in pregnancy, yet women often take it early, especially when a pregnancy arrives unexpectedly and a prescription has already been filled.
The team examined insurance claims involving more than 218,000 respiratory treatments and 6,636 acne treatments in pregnant women. Those who filled doxycycline prescriptions were compared with women given alternatives such as amoxicillin, macrolides or topical clindamycin. The higher miscarriage risk held after accounting for maternal age and previous pregnancies. It was clearest among women treated for respiratory infections and appeared in both commercial and Medicaid data. For acne, the signal was weaker and seen only in commercial records.
Outside experts stressed that the study shows association, not cause. Dr Linda Gallo noted that doxycycline is often the option when severe acne resists topical treatment, and that the findings call for careful weighing of risk and benefit. Prof Janna Morrison pointed out that the study says nothing about babies born at term, and that animal research alone hints at possible DNA damage in embryos.
Prof Kelton Tremellen offered the most practical guidance: where suitable alternatives exist, doctors should consider avoiding doxycycline in women of childbearing age who are not using reliable contraception. Penicillin and macrolides showed no such link here. The open questions now are whether further research can establish a cause, and what the drug does in pregnancies that continue.
Researchers at the University of Florida have reported a connection between doxycycline, a widely prescribed antibiotic, and a higher chance of miscarriage when it is taken in the first trimester of pregnancy.
Doxycycline is commonly used for urinary tract infections and acne, both frequent complaints among women. It is also used for respiratory tract infections. The drug is not recommended during pregnancy, but the Florida team noted that women do end up taking it in early pregnancy, for instance when a pregnancy is unexpected and a prescription has already been filled.
To examine the effect, the team went through healthcare claims for pregnant women who had been given either doxycycline or a different antibiotic during that early window. More than 218,000 of the claims involved women prescribed antibiotics for respiratory tract infections. Another 6,636 involved pregnant women being treated for acne.
The comparison was between women who filled a doxycycline prescription in the first trimester and women treated with other drugs. For respiratory infections, the alternatives included amoxicillin and macrolides. For acne, the comparison drug was topical clindamycin. Women exposed to doxycycline had a significantly higher risk of miscarriage than those given the alternatives. The result held after the researchers accounted for factors such as age, since older mothers are more likely to miscarry, and for earlier pregnancies and births.
The association was strongest among women taking doxycycline for respiratory infections, and it appeared in both of the databases examined, commercial claims and Medicaid. Among women treated for acne the signal was weaker, and the increased risk of pregnancy loss showed up only in the commercial claims data.
Outside experts were careful about what the findings can carry. Dr Linda Gallo of the University of the Sunshine Coast, who was not involved, said the study cannot show that doxycycline causes pregnancy loss, only that the two are linked. She noted that doxycycline is a common option for severe acne when topical treatments fail, and that acne disproportionately affects young adult women. Even so, she said the results are an important warning to weigh risk against benefit. The drug is generally avoided in pregnancy, especially from the second trimester, because of known effects on foetal bone and tooth development, but with many pregnancies unplanned, early exposure happens. She said the study gives clinicians more reason to think hard about antibiotic choice for women of reproductive age.
Prof Janna Morrison of Adelaide University pointed to a key limitation: the study looked only at pregnancy loss, so it says nothing about babies carried to term. So far, she indicated, only animal studies suggest the drug may damage DNA in embryos. She added that many women need medication for health conditions during pregnancy, yet the effects on pregnancy and the developing foetus remain understudied, and that more research is needed on both early loss and the longer-term health of babies.
Prof Kelton Tremellen of Flinders University offered the most practical reading. Doctors, he said, should consider avoiding doxycycline in women of childbearing age who are not using reliable contraception, where suitable alternatives exist. He also noted that penicillin and macrolide antibiotics were not linked to a higher miscarriage risk in this study.
The next questions are whether further research can establish a cause, and what the drug does in pregnancies that continue.
Citas Notables
The findings serve as an important warning to balance potential risk with benefits.— Dr Linda Gallo, University of the Sunshine Coast
Doctors should consider avoiding doxycycline in women of childbearing age not using reliable contraception, where suitable alternatives are available.— Prof Kelton Tremellen, Flinders University
Quieres la nota completa?
Lee el original en The Sun ↗